Clarithromycin in 2003: sustained efficacy and safety in an era of rising antibiotic resistance

International Journal of Antimicrobial Agents
A Anzueto, Sandra Norris

Abstract

Data from surveillance studies show increasing prevalence of respiratory pathogens resistant to commonly used antibiotics. Thus, a Medline search was conducted to identify studies of clarithromycin, especially those addressing macrolide resistance. Changing trends of in vitro susceptibility have not affected clinical efficacy with clarithromycin. Over the last 12 years, clarithromycin study results have shown consistent rates of clinical cure and bacteriological eradication, which are similar to those observed with comparator agents. The incidence of clarithromycin treatment failure in patients infected with Streptococcus pneumoniae is substantially less than that predicted by macrolide resistance rates from surveillance programmes. In summary, despite widespread use since its introduction, clarithromycin remains active both in vitro and in vivo against clinically relevant respiratory tract pathogens.

References

Jul 1, 1992·Antimicrobial Agents and Chemotherapy·M R HammerschlagP M Roblin
May 1, 1992·Antimicrobial Agents and Chemotherapy·S Y ChuJ Cavanaugh
Aug 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D M JohnsonR N Jones
Sep 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E LozaB Garijo
Sep 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A L Barry
Mar 1, 1992·Diagnostic Microbiology and Infectious Disease·W W HooverR N Jones
Jan 1, 1991·Respiration; International Review of Thoracic Diseases·H NagaiA Kurashima
Feb 1, 1991·The Journal of Antimicrobial Chemotherapy·J H Levenstein
Nov 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G E SteinN Mummaw
Dec 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A L BarryM A Pfaller
Nov 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H Renaudin, C Bébéar
Dec 1, 1990·The Journal of Antimicrobial Chemotherapy·L E FenelonG L Ridgway
Aug 1, 1989·Antimicrobial Agents and Chemotherapy·S B LevyD E Taylor
Dec 1, 1986·Antimicrobial Agents and Chemotherapy·P B FernandesE Gade
Feb 1, 1987·European Journal of Clinical Microbiology·R L HodinkaP H Gilligan
Nov 1, 1987·The Journal of Antimicrobial Chemotherapy·G M EliopoulosR C Moellering
Oct 1, 1988·Antimicrobial Agents and Chemotherapy·K B WaitesP B Fernandes
Dec 1, 1988·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A M SeftonJ D Williams
Nov 1, 1988·Antimicrobial Agents and Chemotherapy·D J HardyP B Fernandes
Feb 1, 1987·Annals of Internal Medicine·N R AnthonisenN A Nelson
Apr 1, 1994·Antimicrobial Agents and Chemotherapy·D N FishK A Rodvold
Dec 1, 1993·The Pediatric Infectious Disease Journal·J C Craft, N Siepman
Oct 1, 1996·Diagnostic Microbiology and Infectious Disease·V D ShortridgeS K Tanaka
Jun 1, 1997·American Journal of Respiratory and Critical Care Medicine·B K RubinR Palmer
Jul 1, 1997·The Journal of Antimicrobial Chemotherapy·A PikisW J Rodriguez
May 13, 1998·The Journal of Antimicrobial Chemotherapy·C E GoldsmithJ E Ambler
Nov 3, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S ChodoshS Kowalsky
Nov 3, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G V DoernR N Jones
Feb 13, 1999·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·A CorsoA Tomasz
Mar 25, 1999·Clinical Therapeutics·J RamirezL Townsend
Jun 3, 1999·American Journal of Respiratory and Critical Care Medicine·S EwigJ Mensa

❮ Previous
Next ❯

Citations

Dec 22, 2006·Expert Review of Anti-infective Therapy·Daryl J Hoban, George G Zhanel
Feb 10, 2007·Current Medical Research and Opinion·Mark GotfriedGerard F Notario
Jan 1, 2008·Nutrition Research and Practice·Hyung-Sook KimHaymie Choi
Nov 28, 2006·Animal Biotechnology·Björn Bengtsson, Martin Wierup
Apr 5, 2005·Indian Journal of Medical Sciences·Rashmi SharmaBhuvneshwar Kapoor

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.